Caitlin Elgarten is an Oncology physician affiliated with Children's Hospital of Philadelphia. OpenAlex indexes 102 publications with 691 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3500 Civic Center Blvd
Philadelphia, PA 191044395
Telephone
215-590-1000Registry record last updated 30 Aug 2018.
Clinical trials
- CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Sponsor: Children's Hospital of Philadelphia
- A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Sponsor: Children's Oncology Group
- Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
Sponsor: Stephan Grupp MD PhD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pierre Fabre Pharmaceuticals, Inc.Program year20256 payments
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Understanding longitudinal microbiome change in relation to immunologic outcomes in pediatric SCT recipients.
Children'S Hosp of Philadelphia
FY2026$164,052K23HL161309 - Understanding longitudinal microbiome change in relation to immunologic outcomes in pediatric SCT recipients.
Children'S Hosp of Philadelphia
FY2025$185,652K23HL161309 - Understanding longitudinal microbiome change in relation to immunologic outcomes in pediatric SCT recipients.
Children'S Hosp of Philadelphia
FY2024$185,652K23HL161309
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CAR T cell therapy for children with rheumatic disease: the time is now
Nature Reviews Rheumatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Grupp, MD
Children's Hospital of Philadelphia
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jonathan Spergel, MD
Children's Hospital of Philadelphia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”